Lixisenatide CAS:320367-13-3

Lixisenatide helps lower blood sugar levels after meals, reduces fasting blood glucose levels, and promotes weight loss. By mimicking the effects of incretin hormones, it improves pancreatic function and insulin sensitivity, resulting in improved glucose utilization by the body. Additionally, Lixisenatide slows down gastric emptying, which helps regulate postprandial glucose levels and reduces the risk of hypoglycemia. Apart from its glucose-lowering effects, Lixisenatide has shown benefits in cardiovascular health by reducing the risk of major adverse cardiovascular events in patients with type 2 diabetes who are at high cardiovascular risk. It is also associated with reduced systolic blood pressure and improved lipid profiles. Lixisenatide is a valuable treatment option for individuals with type 2 diabetes who require additional support in managing their blood sugar levels and reducing cardiovascular risk factors.